Drugs / unlabelled hMAb BIWA 4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02204033 | Mar 1999 → Jun 2001 | head and neck neoplasm | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | unlabelled hMAb BIWA 4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02204033 ↗ |
| Modality | Monoclonal antibody | “Humanised Monoclonal Antibody BIWA 4” NCT02204033 ↗ |